Highbridge Capital Management’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-30,973	Closed	-$474K	–	798
2014 Q1	$474K	Buy	+30,973	New	+$474K	0.01%	521